BioServe Selected for Genetic Study on Thoracic Aortic Disease

 

June 18, 2007

June 18, 2007 – BioServe today announced that it has been selected by Houston-based Specialized Clinical Center of Research (SCCOR) for a novel study aimed at identifying the genetic cause of thoracic aortic disease, in which the company will provide SCCOR researchers with access to unique sample sets from its Global Repository of over 600,000 human DNA, tissue and serum samples linked to detailed clinical and demographic data to assist in identifying genes that are predictive of the development and progression of thoracic aortic diseases.

SCCOR is a collaborative program by University of Texas Health Science Center Houston, Baylor College of Medicine and University of Texas Medical Branch leading a study to define DNA sequence variants in target genes and their interacting environmental risk factors responsible for a significant proportion of the thoracic aortic diseases.

“By identifying the underlying and specific genetic causes of thoracic aortic disease we will provide doctors with the ability to predict which patients are at higher risk of aortic rupture, and treat them earlier,” said Xin Li Wang, a professor and director in the cardiothoracic research laboratory in the division of cardiothoracic surgery of the Michael E. DeBakey Department of Surgery at Baylor College of Medicine.

For more information: www.bioserve.com